PRKG1 and glioblastoma: Restoring sGC with an active sGC mutant (sGCα1β1(Cys105)) suppressed glioblastoma cell growth and increased the survival time in nude mice bearing a glioblastoma xenograft [10], which is consistent with the notion that the cGMP–PKG signaling pathway negatively regulates GBM progression/development.